NSE: ZENSARTECH | BSE: 504067

Falling Comet

Download real time

477.85 -7.05 (-1.45%)

45.01% Fall from 52W High

572.4K NSE+BSE Volume

NSE 19 Aug, 2026 3:31 PM (IST)

10,873.7

Market Cap

High in industry

Beta 1Year

Average volatility

Zensar Technologies Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for ZENSARTECH, BSE:504067 Zensar Technologies Ltd.

Search Inside the pdf :

Zensar Technologies Ltd.

30 Jul 2026

477.85

-1.45%

Zensar Technologies: Q1FY27 Result Review

Hold: Zensar Technologies Ltd.

Target

IDBI Capital

Zensar delivered a mixed performance in Q1FY27; Revenue grew a modest 1.1% QoQ CC to USD 159.5mn, powered by BFSI (+8.3% QoQ) and early ramp-up of the ~USD 210mn mega deal, while HLS, MCS and TMT continued to bleed (-2.3% to -9.1%), extending a two-quarter pattern of broad-based softness outside financial services. Margins contracted 150bps on pre-staffing costs for the large deal and elevated SG&A/travel spend, with management guiding flattish margins through Q2/Q3 before recovery from Q3FY27. Order book...

Zensar Technologies has lost -40.12% in the last 1 Year

Zensar Technologies Ltd.

30 Jul 2026

477.85

-1.45%

Slow recovery through FY27

Buy: Zensar Technologies Ltd.

Target

Motilal Oswal

Zensar (ZENT) reported 1QFY27 revenue growth of 1.1% QoQ CC (est. flat QoQ CC). BFSI grew 8.3% QoQ CC, while TMT/HLS/MCS declined 9.1%/3.8%/2.3% QoQ CC.

Zensar Technologies has lost -40.12% in the last 1 Year

Zensar Technologies Ltd.

26 May 2026

477.85

-1.45%

Moving step by step

Buy: Zensar Technologies Ltd.

Motilal Oswal

We attended Zensar Technologies (ZENT)’s analyst meeting, where discussions were centered on AI strategy, growth outlook, pricing changes, and M&A.

Zensar Technologies .. has an average target of 561.75 from 4 brokers.

Zensar Technologies Ltd.

27 Apr 2026

477.85

-1.45%

Result Update:Zensar Tech.

Hold: Zensar Technologies Ltd.

Target

Axis Direct

We maintain a HOLD rating on the stock.

Zensar Technologies has lost -40.12% in the last 1 Year

Zensar Technologies Ltd.

26 Apr 2026

477.85

-1.45%

Zensar Technologies (SELL): Higher competitive intensity flagged off

Sell: Zensar Technologies Ltd.

Target

BOB Capital Markets Ltd.

4QFY26 came in weaker than our estimate driven by weakness in TMT and late booking of a mega deal

Zensar Technologies Ltd. is trading below all available SMAs

Zensar Technologies Ltd.

25 Apr 2026

477.85

-1.45%

Recovery to follow steadily

Buy: Zensar Technologies Ltd.

Target

Motilal Oswal

Zensar (ZENT) reported 4QFY26 with a revenue decline of 1.9% QoQ CC (est. a decline of 1.8% CC).

Number of FII/FPI investors decreased from 243 to 229 in Jun 2026 qtr

Zensar Technologies Ltd.

27 Jan 2026

477.85

-1.45%

Result Update:Zensar Tech.

Hold: Zensar Technologies Ltd.

Target

Axis Direct

We maintain our Hold rating on the stock.

Zensar Technologies Ltd. is trading below all available SMAs

Zensar Technologies Ltd.

24 Jan 2026

477.85

-1.45%

Zensar Technologies (SELL): Remains growth challenged

Sell: Zensar Technologies Ltd.

Target

BOB Capital Markets Ltd.

3Q revenue came in short but EBIT margin at 16.1% positively surprised on offshore volume shift. TMT sector continues to be a drag

Zensar Technologies has lost -40.12% in the last 1 Year

Zensar Technologies Ltd.

23 Jan 2026

477.85

-1.45%

Revenue recovery still in progress

Buy: Zensar Technologies Ltd.

Recommendation Target

Motilal Oswal

Zensar (ZENT)’s 3QFY26 revenue declined 1.3% QoQ CC (vs. our est. of a 1.7% CC decline). MCS grew 3.4% QoQ CC, while TMT/HLS dipped 8.7%/2.3% QoQ CC.

Zensar Technologies Ltd. is trading below all available SMAs

Zensar Technologies Ltd.

23 Jan 2026

477.85

-1.45%

Zensar Technologies: Q3FY26 Result Review

Hold: Zensar Technologies Ltd.

Target

IDBI Capital

Zensar delivered a resilient Q3FY26 performance in a challenging demand environment, with revenue of USD 160.5mn, growing 1.3%YoY in CC term, supported by healthy offshore volume growth. While topline growth remains modest due to continued weakness in the TMT vertical and some pressure in healthcare, the company's execution on profitability was strong. EBITDA margin expanded sharply by 200 basis points sequentially to 17.4%, driven by better offshore mix, higher utilization, forex benefits, and tight cost control. The order book improved to ~USD 180mn with a book-to-bill of 1.12x, providing...

Number of FII/FPI investors decreased from 243 to 229 in Jun 2026 qtr

Is Zensar Technologies Ltd. worth buying?

456 Votes:

Buy 84.65%

Sell 7.24%

Hold 8.11%

RESEARCH REPORTS

Hold SEE REPORTS >

pdf

Buy SEE REPORTS >

pdf